TumCP Cancer Research Results

TumCP, Tumor Cell proliferation: Click to Expand ⟱
Source:
Type:
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
Scientific Papers found: Click to Expand⟱
4908- Sal,    Salinomycin triggers prostate cancer cell apoptosis by inducing oxidative and endoplasmic reticulum stress via suppressing Nrf2 signaling
- in-vitro, Pca, PC3 - in-vitro, Pca, DU145
tumCV↓, ROS↑, lipid-P↑, UPR↑, ER Stress↑, NRF2↓, NADPH↓, HO-1↓, SOD↓, Catalase↓, GPx↓, eff↓, TumCP↓,
4909- Sal,    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model
- vitro+vivo, CRC, NA
AntiTum↑, Apoptosis↑, mtDam↑, ROS↑, SOD1↓, ChemoSen↑, CSCs↑, ALDH↓, TumCG↓, TumCP↓, TumCD↑, ATP↓,
5127- Sal,    Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
- in-vitro, Ovarian, NA
TumCI↓, E-cadherin↑, N-cadherin↓, Vim↓, Wnt↓, β-catenin/ZEB1↓, TumCP↓, TumCMig↓, EMT↓,
6445- SAO,    Antineoplastic Effects of α-Santalol on Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Cells through Cell Cycle Arrest at G2/M Phase and Induction of Apoptosis
- in-vitro, BC, MDA-MB-231 - in-vitro, Nor, MCF10 - in-vitro, BC, MCF-10AT
tumCV↓, TumCP↓, selectivity↑, TumCCA↑, DNAdam↑, Casp↑, cl‑PARP↑, Casp3↑, Casp6↑, Casp7↑,
6451- SAO,    α-Santalol functionalized chitosan nanoparticles as efficient inhibitors of polo-like kinase in triple negative breast cancer
- vitro+vivo, BC, MDA-MB-231
TumCP↓, selectivity↑, Bcl-2↓, PLK1↓, BAD↑, Casp↑, BAX↑, Dose↝, TumCG↓,
5139- SAS,    Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis
- in-vitro, OS, MG63 - in-vitro, OS, U2OS
*Inflam↓, TumCP↓, TumCMig↓, Apoptosis↑, Ferroptosis↑, Iron↑, MDA↑, ROS↑, GSH↓, SOD↓, MMP↓, NRF2↓, xCT/SLC7A11↓, GPx4↓, FTH1↓,
5035- SAS,    Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use
- Human, GC, NA - in-vitro, GC, NCI-N87 - in-vitro, GC, SGC-7901
other?, TumCP↓, TumMeta↓, TumCI↓, xCT/SLC7A11↓, OS↑,
6220- Se,  CUR,  Rad,    Selenium-Curcumin-PEG Nanoparticles Radiosensitization for Intensity-Modulated Radiation Therapy of Lung Tumor Cells: In Vitro Synergistic Combination Therapy
- in-vitro, Lung, A549
RadioS↑, TumCD↑, ROS↑, Imm↑, angioG↓, BioAv↑, TumCP↓, Apoptosis↓, TumMeta↓, CompStab↑,
4483- Se,  Chit,    Anti-cancer potential of chitosan-starch selenium Nanocomposite: Targeting osteoblastoma and insights of molecular docking
- in-vitro, OS, NA
AntiCan↑, TumCP↓, Apoptosis↑, ROS↑, eff↑, other↝, eff↑, TumCCA↑,
4714- Se,  SSE,  SeNPs,    Selenium in cancer management: exploring the therapeutic potential
- Review, Var, NA
Risk↓, *BioAv↑, eff↝, *ROS↓, MMP↓, ROS↑, P53↑, *toxicity↓, TumCP↓, Casp↑, Apoptosis↑,
9281- SES, SSM,  LIGs,    A comprehensive review on the anti-cancer properties of sesame lignans: chemical composition, molecular mechanisms and prospects
- Review, Var, NA
Ingr↝, ChemoSen↑, *Sleep↑, *antiOx↑, *GPx↑, *GSR↑, *GSH↑, *MDA↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, CDK2↓, P53↑, COX2/PTGS2↓, TumCP↓, Apoptosis↑, DNAdam↑, cl‑Casp3↑, NF-kB↓, ROS↑, MMP↓, VEGF↓, MMP9↓, Hif1a↓,
9276- SES, SSM,    Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products
- in-vitro, Var, NA
TumCP↓, Apoptosis↑, Bcl-2↓, survivin↓, cycD1/CCND1↓, Inflam↓, COX2/PTGS2↓, TumCI↓, MMP9↓, ICAM-1↓, NF-kB↓,
9280- SES, SSM,    A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum)
- Review, Var, NA
AntiCan↑, TumCP↓, Apoptosis↑, Inflam↓, TumMeta↓, angioG↓, ROS↓, TumAuto↓,
3197- SFN,    Sulforaphane Inhibits Self-renewal of Lung Cancer Stem Cells Through the Modulation of Polyhomeotic Homolog 3 and Sonic Hedgehog Signaling Pathways
- in-vitro, Lung, A549 - in-vitro, Lung, H460
TumCP↓, CSCs↓, Shh↓, Smo↓, Gli1↓,
3192- SFN,    Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention
- in-vitro, Pca, PC3
Sp1/3/4↓, selectivity↑, NRF2↑, HDAC↓, DNMTs↓, TumCCA↑, selectivity↑, HO-1↑, NQO1↑, CDK2↓, TumCP↓, BID↑, Smad1↑, Diablo↑, ICAD↑, Cyt‑c↑, IAP1↑, HSP27↑, *Cyt‑c↓, *IAP1↓, *HSP27↓, survivin↓, CDK4↓, VEGF↓, AR↓,
2164- SFN,  dietP,    Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice
- in-vitro, Pca, NA
HDAC↓, Dose↝, Risk↓, TumCP↓, H3↓,
2405- SFN,    Sulforaphane Targets the TBX15/KIF2C Pathway to Repress Glycolysis and Cell Proliferation in Gastric Carcinoma Cells
- in-vitro, GC, SGC-7901 - in-vitro, GC, BGC-823
TumCP↓, Glycolysis↓, TBX15↑, GlucoseCon↓, lactateProd↓, tumCV↓, PKM2↓, KIF2C↓,
2446- SFN,  CAP,    The Molecular Effects of Sulforaphane and Capsaicin on Metabolism upon Androgen and Tip60 Activation of Androgen Receptor
- in-vitro, Pca, LNCaP
AR↓, Bcl-xL↓, TumCP↓, Glycolysis↓, HK2↓, PKA↓, Hif1a↓, PSA↓, ECAR↓, BioAv↑, BioAv↓, *toxicity↓,
1471- SFN,    ROS-mediated activation of AMPK plays a critical role in sulforaphane-induced apoptosis and mitotic arrest in AGS human gastric cancer cells
- in-vitro, GC, AGS
TumCP↓, Apoptosis↑, TumCCA↑, CycB/CCNB1↑, P21↑, p‑H3↑, p‑AMPK↑, eff↓, MMP↓, Cyt‑c↑, ROS↑, eff↓,
1469- SFN,    Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis
- in-vitro, Pca, PC3 - in-vitro, Pca, LNCaP - in-vivo, Pca, NA
Synergy↑, ROS↑, MMP↓, Casp3↑, Casp9↑, DR4↑, DR5↑, BAX↑, Bak↑, BIM↑, NOXA↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, eff↓, TumCG↓, TumCP↓, eff↑, NF-kB↓, PI3K↓, Akt↓, MEK↓, ERK↓, angioG↓, FOXO3↑,
1466- SFN,    Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
- vitro+vivo, Thyroid, FTC-133
TumCP↓, TumCCA↑, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, Slug↓, Twist↓, MMP2↓, MMP9↓, TumCG↓, p‑Akt↓, P21↑, ERK↑, p38↑, ROS↑, *toxicity∅, MMP↓, eff↓,
1461- SFN,    Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer - contradictory effects and future perspectives
- Review, BC, NA
TumCP↓, Apoptosis↑, TumCCA↑, antiOx↑,
1472- SFN,    Sulforaphane Inhibits Autophagy and Induces Exosome-Mediated Paracrine Senescence via Regulating mTOR/TFE3
- in-vitro, ESCC, NA
TumCP↓, ROS↑, DNAdam↑,
1457- SFN,    Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells
- in-vitro, CRC, HT-29
IL6↓, ROS↓, TumCP↓, TumCI↓, p38↓, AP-1↓,
1456- SFN,    Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells
- in-vitro, PC, MIA PaCa-2 - in-vitro, PC, PANC1
tumCV↓, TumCP↓, cl‑PARP↑, cl‑Casp3↑, TumCCA↑, ROS↑, MMP↓, γH2AX↑, eff↓, *toxicity↓,
1453- SFN,    Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
TumCG↓, TumCP↓, TumCCA↑, H3↑, H4↑, HDAC↓, CDK1↑, CDK2↑, p19↑, *BioAv↑,
1434- SFN,  GEM,    Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
- in-vitro, CCA, HuCCT1 - in-vitro, CCA, HuH28 - in-vivo, NA, NA
HDAC↓, ac‑H3↑, ChemoSen↑, tumCV↓, TumCP↓, TumCCA↑, Apoptosis↑, cl‑Casp3↑, TumCI↓, VEGF↓, VEGFR2/KDR/Flk1↓, Hif1a↓, eNOS↓, EMT?, TumCG↓, Ki-67↓, TUNEL↑, P21↑, p‑Chk2↑, CDC25↓, BAX↑, *ROS↓, NQO1?,
1509- SFN,    Combination therapy in combating cancer
- Review, Var, NA
NRF2↑, ChemoSideEff↓, eff↑, TumCP↓, Apoptosis↑, TumCCA↑, ChemoSen↑, PSA↓, P53↑, Hif1a↓, CAIX/CA9↓, chemoR↓, 5HT↓,
1475- SFN,  Form,    Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway
- in-vitro, Cerv, HeLa
TumCP↓, PI3K↓, Akt↓, mTOR↓, Synergy↑, ROS↑,
1315- SFN,    Sulforaphane Induces Apoptosis of Acute Human Leukemia Cells Through Modulation of Bax, Bcl-2 and Caspase-3
- in-vitro, AML, K562
TumCP↓, BAX↑, Casp3↑, Bcl-2↓,
1734- SFN,    Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1α-Mediated Glycolysis in Hypoxia
- in-vitro, Bladder, RT112
selectivity↑, TumCP↓, Glycolysis↓, Hif1a↓,
3305- SIL,    Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vivo, NA, NA
TumCP↓, tumCV↓, BAX↑, cl‑PARP↑, Casp9↑, p‑JNK↑, Bcl-2↓, p‑p38↓, p‑ERK↓, *toxicity∅, Dose↝, *hepatoP↑, Inflam↓, AntiCan↑,
3297- SIL,  Rad,    Studies on radiation sensitization efficacy by silymarin in colon carcinoma cells
- in-vitro, CRC, HCT15 - in-vitro, CRC, RKO
TumCP↓, RadioS↑, TumCCA↑, DNAdam↓, MMP↓, ROS↓, *radioP↑,
3296- SIL,    Silibinin induces oral cancer cell apoptosis and reactive oxygen species generation by activating the JNK/c-Jun pathway
- in-vitro, Oral, Ca9-22 - in-vivo, Oral, YD10B
TumCP↓, TumCCA↑, ROS↑, SOD1↓, SOD2↓, *JNK↑, toxicity?, TumCMig↓, TumCI↓, N-cadherin↓, Vim↓, E-cadherin↑, EMT↓, P53↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, Bcl-2↓, SOD↓,
3323- SIL,    Anticancer therapeutic potential of silibinin: current trends, scope and relevance
- Review, Var, NA
Inflam↓, angioG↓, antiOx↑, TumMeta↓, TumCP↓, TumCCA↑, TumCD↑, α-SMA↓, p‑Akt↓, p‑STAT3↓, COX2/PTGS2↓, IL6↓, MMP2↓, HIF-1↓, Snail↓, Slug↓, Zeb1↓, NF-kB↓, p‑EGFR↓, JAK2↓, PI3K↓, PD-L1↓, VEGF↓, CDK4↓, CDK2↓, cycD1/CCND1↓, E2Fs↓,
3326- SIL,    Silymarin suppresses proliferation of human hepatocellular carcinoma cells under hypoxia through downregulation of the HIF-1α/VEGF pathway
- in-vitro, Liver, HepG2 - in-vitro, Liver, Hep3B
*hepatoP↑, chemoPv↑, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, Hif1a↓, VEGF↓, angioG↓,
3646- SIL,    "Silymarin", a promising pharmacological agent for treatment of diseases
- Review, Var, NA
*P-gp/ABCB1↓, *Inflam↓, *hepatoP↑, *antiOx↑, *GSH↑, *BioAv↑, *SOD↑, *IFN-γ↓, *IL4↓, *IL10↓, *Half-Life↓, *TNF-α↓, *ALAT↓, *AST↓, Akt↓, chemoP↑, β-catenin/ZEB1↓, TumCP↓, MMP↓, Cyt‑c↑, *RenoP↑, *BBB↑,
1140- SIL,    Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
- in-vitro, PC, AsPC-1 - in-vivo, PC, NA - in-vitro, PC, MIA PaCa-2 - in-vitro, PC, PANC1 - in-vitro, PC, Bxpc-3
TumCG↓, Glycolysis↓, cMyc↓, STAT3↓, TumCP↓, Weight∅, Strength↑, DNAdam↑, Casp3↑, Casp9↑, GLUT1↓, HK2↓, LDHA↓, GlucoseCon↓, lactateProd↓, PPP↓, Ki-67↓, p‑STAT3↓, cachexia↓,
1127- SIL,    Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
- in-vitro, Lung, A549
TumCP↓, TumCMig↓, TumCI↓, EMT↓, RHBDD1↓,
964- SIL,    Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics
- vitro+vivo, Pca, LNCaP - in-vitro, Pca, 22Rv1
TumCP↓, Hif1a↓, NADPH↓, angioG↓, FASN↓, ACC↓,
978- SIL,    A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment
- Review, Var, NA
PI3K↓, Akt↓, NF-kB↓, Wnt/(β-catenin)↓, MAPK↓, TumCP↓, TumCCA↑, Apoptosis↑, p‑EGFR↓, JAK2↓, STAT5↓, cycD1/CCND1↓, hTERT/TERT↓, AP-1↓, MMP9↓, miR-21↓, miR-155↓, Casp9↑, BID↑, ERK↓, Akt2↓, DNMT1↓, P53↑, survivin↓, Casp3↑, ROS↑,
965- SK,    Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling
- in-vitro, CRC, HCT116 - in-vitro, CRC, SW-620
Hif1a↓, ROS↓, mTOR↓, p70S6↓, 4E-BP1↓, eIF2α↓, TumCCA↑, TumCP↓, Half-Life↝,
1073- SK,  Chemo,    Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells
- in-vitro, PC, PANC1 - in-vitro, PC, Bxpc-3
PAK1↓, TumCP↓, Apoptosis↑, ChemoSen↑, ROS↑,
2417- SK,    Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer
- in-vitro, Lung, A549 - in-vitro, Lung, H446
TumCP↓, TumCMig↓, TumCI↓, GlucoseCon↓, lactateProd↓, PFKFB2↓, Warburg↓, GLUT1∅, LDHA∅, PKM2∅, GLUT3∅, PDH∅,
2360- SK,    Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway
- in-vitro, NPC, HONE1 - in-vitro, NPC, SUNE-1
TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, GlucoseCon↓, lactateProd↓, ATP↓, PKM2↓, PI3K↓, Akt↓, MMP3↓, MMP9↓, TIMP1↑,
2355- SK,    Pharmacological properties and derivatives of shikonin-A review in recent years
- Review, Var, NA
AntiCan↑, TumCP↓, TumCMig↓, Apoptosis↑, TumAuto↑, Necroptosis↑, ROS↑, TrxR1↓, PKM2↓, RIP1↓, RIP3↓, Src↓, FAK↓, PI3K↓, Akt↓, mTOR↓, GRP58↓, MMPs↓, ATF2↓, cl‑PARP↑, Casp3↑, p‑p38↑, p‑JNK↑, p‑ERK↓,
2234- SK,    Shikonin Suppresses Cell Tumorigenesis in Gastric Cancer Associated with the Inhibition of c-Myc and Yap-1
- in-vitro, GC, NA
TumCP↓, TumCI↓, TumCMig↓, cMyc↓, YAP/TEAD↓,
2198- SK,    Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT/GPX4 regulatory axis
- in-vitro, OS, MG63 - in-vitro, OS, 143B
TumCP↓, TumCCA↑, Ferroptosis↑, Iron↑, ROS↑, lipid-P↑, MDA↑, mtDam↑, NRF2↓, xCT/SLC7A11↓, GPx4↓, GSH/GSSG↓, Keap1↑,
2195- SK,    Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1α/HO-1 axis
- in-vitro, OS, NA
TumCP↓, Ferroptosis↓, Hif1a↑, HO-1↑, Iron↑, ROS↑, GSH/GSSG↓, GPx4↓,
2192- SK,    Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation
- in-vitro, ESCC, KYSE-510 - in-vitro, ESCC, Eca109 - in-vivo, NA, NA
TumCP↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, p‑PKM2↓, p‑STAT3↓, GLUT1↓, HK2↓, TumW↓,

Showing Research Papers: 1151 to 1200 of 1302
Prev Page 24 of 27 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1302

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 2,   NA↑, 4,   NA↝, 1,   NA?, 1,   NA∅, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 2,   antiOx↓, 5,   antiOx↑, 25,   antiOx⇅, 2,   ARE↑, 1,   ARE/EpRE↑, 1,   Catalase↓, 9,   Catalase↑, 7,   DJ-1↓, 1,   ENOX2↑, 1,   Fenton↑, 4,   GCLC↑, 2,   GPx↓, 4,   GPx↑, 7,   GPx1↓, 1,   GPx4↓, 30,   GPx4↑, 2,   GSH↓, 60,   GSH↑, 12,   GSH/GSSG↓, 10,   GSR↓, 1,   GSR↑, 3,   GSSG↑, 1,   ox-GSSG↑, 1,   GSTs↓, 1,   GSTs↑, 5,   H2O2↓, 3,   H2O2↑, 8,   mt-H2O2↑, 1,   HO-1↓, 9,   HO-1↑, 22,   HO-2↓, 1,   Iron↓, 3,   Iron↑, 19,   i-Iron↑, 5,   c-Iron↑, 1,   Keap1↓, 1,   Keap1↑, 2,   lipid-P↓, 10,   lipid-P↑, 41,   lipid-P↝, 1,   MDA↓, 4,   MDA↑, 20,   i-MDA↑, 2,   MPO↓, 1,   NADH↓, 2,   mt-NADH↑, 1,   NQO1?, 1,   NQO1↓, 1,   NQO1↑, 6,   Nrf1↑, 1,   NRF2↓, 27,   NRF2↑, 33,   NRF2↝, 1,   Prx↓, 1,   Prx3↑, 1,   Prx6↑, 1,   PrxII↓, 2,   RNS↑, 1,   ROS?, 3,   ROS↓, 38,   ROS↑, 412,   ROS⇅, 9,   ROS↝, 6,   ROS∅, 1,   i-ROS↑, 2,   mt-ROS↓, 2,   mt-ROS↑, 15,   selenoP↓, 1,   SOD↓, 13,   SOD↑, 11,   SOD1↓, 4,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 4,   mt-SOD2↑, 1,   TAC↓, 1,   TBARS↓, 1,   Thiols↓, 2,   i-Thiols↓, 1,   TKT↓, 1,   TKT↝, 1,   Trx↓, 3,   Trx↑, 1,   Trx1↓, 1,   Trx1↑, 1,   ox-Trx1↑, 1,   Trx2↓, 1,   TrxR↓, 9,   TrxR1↓, 5,   TrxR1↑, 1,   xCT/SLC7A11↓, 10,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   Ferritin↑, 1,   FPN↝, 1,   FTH1↓, 5,   IronCh↑, 4,   LIP↑, 1,   NCOA4↑, 2,   SFXN2↓, 1,   Tf↑, 2,   TfR1/CD71↓, 1,   TfR1/CD71↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 2,   BCR-ABL↓, 1,   CDC2↓, 5,   CDC25↓, 15,   CDC25↝, 1,   compI↓, 6,   compII↓, 1,   compIII↓, 3,   compV↓, 1,   EGF↓, 4,   ETC↓, 6,   HSP60/HSPD1↓, 2,   Insulin↓, 3,   KIF2C↓, 1,   mitResp↓, 6,   mitResp↑, 1,   MKK7↓, 2,   Mortalin↓, 1,   mtDam?, 1,   mtDam↑, 40,   OCR↓, 13,   OCR↑, 7,   mt-OCR↑, 1,   OXPHOS↓, 6,   OXPHOS↑, 10,   mt-OXPHOS↑, 1,   PDH↓, 1,   PDH↑, 4,   PDH↝, 1,   PDH∅, 1,   PGC-1α↑, 2,   PHB↓, 1,   PINK1↑, 1,   SIRT3↓, 1,   SIRT3↑, 2,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 4,   5-HETE↓, 1,   5LO↓, 3,   ACC↓, 4,   ACC↑, 3,   p‑ACC↑, 1,   ACLY↓, 3,   ACOX1↑, 1,   ACSL1↓, 1,   ACSL4↑, 6,   ALAT↓, 5,   ALAT↑, 1,   ALDOA↓, 2,   ALDOB↑, 1,   AMP↑, 3,   AMPK?, 1,   AMPK↓, 2,   AMPK↑, 42,   p‑AMPK↑, 6,   ATP↓, 47,   ATP↑, 3,   e-ATP↑, 1,   i-ATP↓, 1,   i-ATP↑, 1,   mt-ATP↓, 1,   CAIX/CA9↓, 5,   CAIX/CA9↑, 1,   CBS↑, 1,   CPT1A↓, 1,   CPT1A↑, 1,   DGAT1↓, 1,   ECAR↓, 8,   ECAR↑, 1,   ECAR↝, 1,   ENO1↓, 3,   ENO3↑, 1,   FABP4↓, 1,   FAO↓, 1,   FASN↓, 12,   FASN↑, 1,   FBI-1↓, 1,   FBP1↑, 1,   FBPase↑, 1,   FDG↓, 1,   G6PD↓, 2,   GALNT10↓, 1,   GLO-I↓, 1,   GLS↓, 3,   glucoNG↓, 1,   glucoNG↑, 1,   glucose↓, 6,   GlucoseCon↓, 34,   glut↓, 1,   GlutaM↓, 1,   GlutMet↓, 3,   Glycolysis↓, 84,   Glycolysis↑, 1,   Glycolysis↝, 1,   GPI↓, 1,   GSK‐3β↓, 13,   GSK‐3β↑, 9,   p‑GSK‐3β↓, 7,   H2S↑, 1,   ac‑Histones↑, 1,   HK1↓, 2,   HK2↓, 39,   HK3↑, 1,   HMG-CoA↓, 6,   HSD17B4↓, 1,   IDH1↓, 1,   lactateProd↓, 40,   lactateProd↑, 1,   LDHA↓, 19,   LDHA∅, 1,   LDL↓, 4,   LDL↑, 1,   lipidLev↓, 2,   lipoGen↓, 2,   MCT4↓, 1,   NAD↓, 1,   NADPH↓, 6,   O-Glc↓, 1,   PCK1↑, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 15,   p‑PDK1 / PDPK1↓, 1,   PDKs↓, 1,   PFK↓, 10,   PFK1↓, 6,   PFK2↓, 1,   PFKFB3↓, 2,   PFKFB4?, 1,   PGC1A↑, 1,   PGK1↓, 2,   PGK2↑, 1,   PGM1↓, 1,   PGM1↑, 1,   PGM3↑, 1,   PIP3↑, 1,   PKLR↑, 1,   PKM1↑, 1,   PKM2↓, 37,   PKM2↑, 1,   PKM2∅, 2,   p‑PKM2↓, 1,   polyA↓, 1,   PPP↓, 3,   PYGL↓, 1,   Pyrim↓, 1,   R5P↝, 1,   p‑S6↓, 2,   SCD1↓, 4,   SCP2↓, 1,   SIRT1↓, 8,   SIRT1↑, 10,   SIRT2↓, 1,   SIRT2↑, 1,   SREBF2↓, 1,   SREBP1/SREBF1↓, 6,   SREBP2↓, 2,   TCA↓, 2,   TCA↑, 2,   TPI↓, 1,   TS↓, 3,   TumCM/A↓, 1,   UGDH↓, 2,   Warburg↓, 25,  

Cell Death(tgid=5) ⓘ

AIF↑, 12,   APAF1↑, 9,   Apoptosis?, 6,   Apoptosis↓, 20,   Apoptosis↑, 647,   mt-Apoptosis↑, 4,   ASC↑, 1,   BAD?, 1,   BAD↓, 3,   BAD↑, 19,   p‑BAD↓, 1,   Bak↑, 10,   BAX↓, 6,   BAX↑, 210,   BAX⇅, 1,   BAX↝, 1,   Bax:Bcl2↑, 41,   Bcl-2↓, 223,   Bcl-2↑, 6,   Bcl-2↝, 1,   cl‑Bcl-2↑, 1,   Bcl-xL↓, 46,   Bcl-xL↑, 2,   BID↓, 1,   BID↑, 6,   BIM↑, 7,   BNIP3↑, 2,   BOK↑, 1,   Casp↓, 3,   Casp↑, 53,   Casp↝, 2,   cl‑Casp↑, 3,   Casp1↑, 1,   cl‑Casp1↑, 1,   Casp10↑, 2,   Casp10∅, 1,   Casp12↑, 3,   Casp12↝, 1,   cl‑Casp12↑, 2,   cl‑Casp12↝, 1,   Casp2↑, 3,   Casp3↓, 7,   Casp3↑, 205,   Casp3↝, 2,   cl‑Casp3↓, 1,   cl‑Casp3↑, 84,   proCasp3↓, 1,   proCasp3↑, 3,   CASP4↑, 1,   Casp6↑, 1,   Casp7↓, 1,   Casp7↑, 27,   cl‑Casp7↑, 4,   Casp8↓, 1,   Casp8↑, 44,   Casp8∅, 1,   cl‑Casp8↑, 9,   proCasp8↓, 1,   proCasp8↑, 3,   Casp9↑, 106,   p‑Casp9↑, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 22,   proCasp9↓, 1,   proCasp9↑, 2,   cFLIP↓, 1,   Cupro↑, 1,   Cyt‑c↑, 104,   Cyt‑c↝, 3,   mt-Cyt‑c↓, 1,   Diablo↑, 5,   DIDO1/DIO-1↑, 1,   DR5↑, 21,   DR5∅, 1,   Endon↑, 4,   FADD↑, 8,   FADD∅, 1,   Fas↓, 2,   Fas↑, 21,   FasL↓, 1,   FasL↑, 7,   FasL⇅, 1,   Ferroptosis↓, 2,   Ferroptosis↑, 47,   GranB/GZMB↑, 1,   GRP58↓, 1,   GSDMD↑, 2,   cl‑GSDME↑, 1,   HEY1↓, 1,   IAP1↓, 11,   IAP1↑, 1,   IAP2/BIRC3↓, 2,   ICAD↓, 1,   ICAD↑, 1,   ICD↑, 2,   iNOS↓, 16,   Mcl-1↓, 29,   MDM2↓, 15,   p‑MDM2↓, 1,   MLKL↑, 1,   MOMP↑, 2,   NAIP↓, 1,   Necroptosis↑, 8,   necrosis↑, 4,   NOXA↑, 4,   p38↓, 4,   p38↑, 26,   p‑p38↓, 4,   p‑p38↑, 8,   Paraptosis↑, 1,   Perforin↑, 1,   PUMA↓, 1,   PUMA↑, 7,   Pyro↑, 4,   RIP3↓, 1,   RIP3↑, 2,   p‑RIP3↑, 1,   survivin↓, 72,   TNFR 1↓, 1,   TNFR 1↑, 2,   TRAIL↑, 3,   TRAIL⇅, 1,   TRAILR↑, 3,   TumCD?, 1,   TumCD↓, 2,   TumCD↑, 36,   TumCD∅, 2,   TUNEL↑, 2,   XIAP↓, 31,   YAP/TEAD↓, 12,   YAP/TEAD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 239,   Akt↑, 9,   Akt↝, 1,   p‑Akt↓, 85,   p‑Akt↑, 2,   AKT1↓, 7,   Akt2↓, 3,   AKT3↓, 1,   AMPKα↓, 1,   AMPKα↑, 1,   BCAP↓, 1,   BRAF↓, 1,   CaMKII ↓, 3,   Cavin3↓, 1,   CIP2A↓, 2,   CK2↓, 3,   cMET↓, 3,   p‑cMET↑, 1,   CREB↓, 2,   CREB2↓, 1,   cSrc↓, 3,   DDIT4↑, 1,   EGFR↓, 42,   p‑EGFR↓, 4,   ERK↓, 71,   ERK↑, 9,   ERK↝, 1,   p‑ERK↓, 28,   p‑ERK↑, 6,   FGFR1↓, 2,   FGFR2↓, 1,   FGFR4/CD334↓, 1,   FOXD3↑, 2,   HER2/EBBR2↓, 13,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 2,   Hippo↓, 1,   IGF-1R↓, 10,   IGF-2R↑, 1,   IGFR↓, 4,   IKKα↓, 10,   IKKα↑, 3,   p‑IKKα↓, 2,   ILK↓, 1,   IR↓, 2,   IκB↓, 1,   JAK↓, 11,   JAK1↓, 9,   JAK1↑, 1,   JAK2↓, 23,   p‑JAK2↓, 2,   JNK↓, 6,   JNK↑, 30,   JNK↝, 1,   p‑JNK↓, 1,   p‑JNK↑, 7,   cl‑JNK↑, 1,   LIMK1↓, 1,   MAP2K1/MEK1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK?, 1,   MAPK↓, 49,   MAPK↑, 23,   MAPK↝, 1,   p‑MAPK↓, 1,   p‑MAPK↑, 4,   MARK4↓, 2,   MEK↓, 7,   p‑MEK↓, 3,   p‑MEK↑, 1,   MKK4↓, 1,   mTOR?, 1,   mTOR↓, 124,   mTOR↑, 6,   mTOR⇅, 1,   p‑mTOR↓, 20,   mTORC2↓, 1,   mTORC2↑, 1,   p42↑, 1,   p70S6↓, 2,   p70S6↑, 1,   p‑p70S6↓, 1,   p‑p70S6↑, 1,   P70S6K↓, 7,   p‑P70S6K↓, 3,   p85S6K↓, 1,   P90RSK↓, 1,   p‑P90RSK↑, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 1,   PDGFRB↓, 1,   PFKFB2↓, 1,   PHKG1↑, 1,   PI3K?, 1,   PI3K↓, 168,   PI3K↑, 3,   PI3K↝, 1,   p‑PI3K↓, 23,   PI3K/Akt↓, 6,   PI3k/Akt/mTOR↓, 1,   PI3K/mTOR/ETS2↓, 1,   PKA↓, 4,   PKCδ↓, 14,   PP2A↑, 1,   PRAS40↓, 1,   PRAS40↑, 1,   PRKCQ/PKCθ↓, 1,   PTEN↓, 3,   PTEN↑, 29,   Raf↓, 6,   e-Raf↓, 1,   c-Raf↓, 1,   RAS↓, 13,   RIP1↓, 2,   RIP1↑, 1,   S6K↓, 1,   p‑S6K↓, 1,   SGK1↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 15,   Src↓, 3,   p‑Src↓, 2,   STAT↓, 8,   p‑STAT↓, 1,   STAT3↓, 94,   STAT3↑, 6,   STAT3↝, 1,   p‑STAT3↓, 23,   p‑STAT3↑, 2,   mt-STAT3↓, 1,   STAT4↓, 1,   STAT5↓, 3,   STAT6↓, 2,   STK11/LKB1↑, 1,   p‑STK11/LKB1↑, 1,   THEM4/CTMP↑, 1,   TSC2↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,   ATF2↓, 2,   ATF3↑, 2,   ATF4↑, 14,   p‑ATF4↝, 1,   BRD4↓, 1,   CBP↓, 2,   CBP↑, 1,   ChrMod↑, 1,   cJun↓, 5,   cJun↑, 2,   p‑cJun↓, 1,   p‑cJun↑, 2,   cMyc↓, 54,   cMyc↑, 2,   p‑cMyc↑, 1,   DNMT1↓, 6,   DNMT1↑, 1,   DNMT3A↓, 1,   DNMT3B↓, 2,   DNMTs↓, 7,   EZH2↓, 3,   FOXM1↓, 5,   FOXO↑, 2,   FOXO1↓, 3,   FOXO1↑, 4,   FOXO3↓, 2,   FOXO3↑, 4,   p‑FOXO3↓, 1,   FOXO4↓, 2,   FOXO4↑, 1,   GATA2↑, 1,   GATA3↓, 1,   H3↓, 2,   H3↑, 1,   p‑H3↑, 1,   ac‑H3↑, 3,   ac‑H3↝, 1,   H3K18↓, 1,   H3K27ac∅, 1,   H3K9↓, 2,   H4↑, 2,   ac‑H4↑, 1,   ac‑H4∅, 1,   HATs↓, 4,   HATs↑, 1,   HDAC↓, 25,   HDAC1↓, 6,   HDAC2↓, 3,   HDAC3↓, 3,   HDAC4↓, 1,   HDAC6↓, 2,   HDAC8↓, 1,   HES1↓, 3,   HMTs↓, 1,   HOXB-AS1↓, 1,   IGF2BP3/IMP3/KOC↓, 1,   JPT1/HN1↓, 1,   KISS1↑, 1,   LINC01116↓, 1,   miR-106b↓, 2,   miR-107↑, 2,   miR-10b-5p↓, 1,   miR-122-5p↑, 1,   miR-124-3p↓, 1,   miR-130a↓, 3,   miR-133a-3p↑, 1,   miR-139-5p↑, 2,   miR-143↑, 1,   miR-145↑, 1,   miR-148a↓, 1,   miR-149↑, 1,   miR-155↓, 3,   miR-182-5p↓, 1,   miR-192-5p↑, 1,   miR-19b↓, 2,   miR-205↑, 1,   miR-21↓, 12,   miR-21↝, 1,   miR-215-5p↑, 1,   miR-218↑, 1,   miR-22↑, 2,   miR-221↓, 1,   miR-224↓, 2,   miR-25-5p↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-320a↓, 1,   miR-339-5p↑, 1,   miR-339-5p↝, 1,   miR-340↓, 2,   miR-34a↑, 6,   miR-375↓, 1,   miR-375↑, 2,   miR-384↑, 1,   miR-422a↑, 2,   miR-486↑, 1,   miR-490↑, 1,   miR-590-3p↑, 1,   miR-592↑, 1,   miR-99↑, 1,   MTA2↓, 1,   Myc↓, 5,   Myc↑, 1,   MYCN↓, 1,   MYCN↑, 1,   n-MYC↓, 1,   NDRG1↑, 1,   NNMT↓, 1,   OCT4↓, 11,   OLIG2↓, 1,   other?, 1,   other↓, 5,   other↑, 12,   other↝, 38,   other∅, 1,   PAX2↓, 1,   PCAF↓, 1,   SD↑, 1,   SOX2↓, 10,   SOX4↓, 1,   SOX9↓, 1,   SUV39H↓, 5,   TBX15↑, 1,   TFAP2A↓, 1,   TFE3↑, 1,   TLE1↓, 1,   tumCV↓, 115,   tumCV↑, 4,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 5,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 26,   p‑CHOP/DDIT3↝, 1,   CRT↑, 1,   EDEM↑, 1,   eIF2α↓, 2,   eIF2α↑, 8,   p‑eIF2α↑, 5,   p‑eIF2α↝, 1,   ER Stress↓, 1,   ER Stress↑, 53,   Erlin1↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 15,   GRP94↑, 1,   HSF1↓, 1,   HSP27↓, 3,   HSP27↑, 1,   HSP70/HSPA5↓, 5,   HSP70/HSPA5↑, 5,   e-HSP70/HSPA5↓, 1,   HSP90↓, 21,   HSP90↑, 2,   HTRA↓, 1,   IRE1↓, 1,   IRE1↑, 3,   IRE1∅, 1,   p‑IRE1↑, 1,   NQO2↑, 1,   OTUB2↓, 1,   PDI↑, 2,   PERK↑, 13,   p‑PERK↝, 1,   Proteasome↓, 3,   SERPINH1/HSP47↓, 1,   UPR↓, 1,   UPR↑, 10,   mt-UPR↑, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 2,   ATG16L1↑, 1,   ATG3↓, 1,   ATG3↑, 3,   ATG5↓, 1,   ATG5↑, 10,   ATG7↑, 5,   autolysosome↑, 1,   Beclin-1/ATG6↓, 8,   Beclin-1/ATG6↑, 30,   CTSB↓, 2,   CTSD↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 7,   LC3B↓, 1,   LC3B↑, 3,   LC3B-II↓, 1,   LC3B-II↑, 7,   LC3I↓, 1,   LC3II↓, 2,   LC3II↑, 19,   LC3s↓, 1,   LC3s↑, 2,   lysoMP↑, 2,   MitoP↓, 1,   p62↓, 13,   p62↑, 7,   PARK2↑, 1,   RUBCN↓, 1,   SESN2↑, 2,   TumAuto?, 1,   TumAuto↓, 4,   TumAuto↑, 99,   TumAuto⇅, 1,   TumAuto↝, 2,   mt-TumAuto↑, 1,   ULK1/ATG1↑, 1,   p‑ULK1/ATG1↑, 1,   VMP-1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↑, 1,   ATM↓, 1,   ATM↑, 4,   p‑ATM↑, 1,   ATR↑, 4,   BRCA1↓, 3,   BRCA2↓, 1,   DNAdam↓, 5,   DNAdam↑, 95,   DNArepair↓, 5,   DNArepair↑, 3,   ERCC1↓, 2,   ERCC3↑, 1,   ERCC4/XPF↓, 1,   m-FAM72A↓, 1,   FEN1↓, 2,   hTERT/TERT↓, 13,   Ku70/XRCC6↓, 1,   NHEJ↓, 1,   NKX3.1↑, 1,   P53?, 2,   P53↓, 6,   P53↑, 128,   P53⇅, 1,   P53↝, 4,   p‑P53↓, 1,   p‑P53↑, 6,   p53 Wildtype↓, 1,   PARP↓, 3,   PARP↑, 24,   PARP↝, 2,   cl‑PARP↓, 1,   cl‑PARP↑, 111,   PARP1↑, 4,   cl‑PARP1↑, 3,   PCNA↓, 44,   PCNA↑, 1,   PCNA↝, 1,   POLD1↓, 1,   RAD51↓, 1,   SIRT6↓, 2,   SIRT6↑, 1,   SMG1↑, 1,   Telomerase↓, 13,   TOP1↓, 6,   TOP2↓, 6,   TOP2↑, 1,   TP53↓, 1,   TP53↑, 3,   TRF2↓, 2,   UHRF1↓, 1,   XRCC1↓, 1,   γH2AX↓, 1,   γH2AX↑, 17,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

AURKB↓, 1,   BRD4↓, 1,   CC(CDKs/cyclins)↓, 2,   CDK1↓, 27,   CDK1↑, 5,   CDK1↝, 1,   p‑CDK1↓, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 53,   CDK2↑, 6,   CDK4↓, 61,   CDK4↑, 3,   CDK4∅, 1,   CDK4/6↓, 1,   CDK6↓, 19,   CDK6↑, 3,   CDK6∅, 1,   CDK7↓, 1,   CDK8↓, 2,   CDKN1C/p57↓, 1,   CDKN2C/p18↑, 1,   CHK1↓, 3,   CHK1↑, 4,   CHK1↝, 1,   p‑CHK1↓, 1,   p‑CHK1↑, 1,   Chk2↓, 3,   Chk2↑, 4,   p‑Chk2↑, 1,   Cyc↓, 4,   cycA1/CCNA1↓, 16,   cycA1/CCNA1↑, 2,   CycB/CCNB1↓, 40,   CycB/CCNB1↑, 6,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 144,   cycD1/CCND1↑, 4,   cycD1/CCND1↝, 1,   cycD1/CCND1∅, 1,   CycD3↓, 4,   cycE/CCNE↓, 33,   cycE/CCNE↑, 3,   cycE/CCNE↝, 1,   cycE1↓, 1,   E2F4↑, 1,   E2Fs↓, 7,   E2Fs↑, 1,   FBXO5/EMI1↓, 1,   GADD34↑, 1,   GADD45A↓, 1,   GADD45A↑, 5,   Ki-67↓, 65,   MAD↓, 1,   mitA↑, 4,   MKI67↑, 1,   p19↑, 1,   P21↓, 5,   P21↑, 113,   P21↝, 1,   p‑P21↑, 1,   p27/CDKN1B↓, 5,   p27/CDKN1B↑, 35,   cl‑p27/CDKN1B↓, 1,   PLK1↓, 1,   pRB↓, 4,   p‑pRB↓, 1,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 2,   RRM2↓, 1,   TAp63α↑, 1,   TumCCA?, 3,   TumCCA↓, 13,   TumCCA↑, 418,   WEE1↑, 3,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 2,   ALDH↓, 5,   ALDH1A1↓, 4,   ALDH1A3↓, 1,   AXIN1↓, 1,   AXIN1↑, 3,   BMI1↓, 2,   BMP7/OP1↓, 2,   CD133↓, 15,   CD24↓, 6,   CD34↓, 2,   cFos↓, 7,   cMYB↓, 1,   CSCs?, 1,   CSCs↓, 62,   CSCs↑, 3,   CSCsMark↓, 1,   Diff↓, 1,   Diff↑, 11,   EIF4E↓, 1,   EP2↓, 1,   EP4/PTGER4↓, 2,   FGF↓, 3,   GH↓, 1,   Gli1↓, 14,   HH?, 1,   HH↓, 22,   HMGCR↓, 2,   IGF-1↓, 10,   IGF-1↑, 1,   IGF-2↓, 1,   IGF-2↑, 1,   IGFBP1↑, 1,   IGFBP3↑, 2,   JAG1↓, 1,   Jun↓, 2,   Ki-67↓, 65,   Let-7↑, 3,   LRP6↓, 2,   MCM2↓, 1,   mTORC1↓, 4,   Nanog↓, 11,   Nestin↓, 1,   NICD↓, 1,   NKD2↑, 2,   NOTCH↓, 14,   NOTCH↑, 2,   NOTCH1↓, 11,   NOTCH1↑, 1,   NOTCH1↝, 1,   NOTCH2↓, 1,   NOTCH3↓, 3,   OGF↑, 1,   OGFr↑, 4,   p300↓, 3,   PCLAF↓, 1,   Piezo1↑, 1,   circ‑PLEKHM3↑, 1,   PTCH1↓, 2,   SCF↓, 1,   Shh↓, 10,   Smo↓, 6,   Smo∅, 1,   TAZ↓, 2,   TumCG?, 3,   TumCG↓, 213,   TumCG↑, 7,   TumCG↝, 1,   TumCG∅, 1,   TumCP?, 6,   TumCP↓, 1259,   TumCP↑, 26,   TumCP⇅, 6,   TumCP∅, 5,   p‑TumCP↓, 1,   tyrosinase↓, 2,   WDR72↓, 1,   Wnt↓, 57,   Wnt/(β-catenin)↓, 9,   ZFX↓, 2,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AGRN↓, 1,   annexin II↓, 1,   AntiAg?, 1,   AntiAg↑, 1,   AP-1↓, 12,   AP-1↝, 1,   ASAP2↓, 1,   ATPase↓, 2,   AXL↓, 2,   BACH1↓, 1,   BACH1↑, 1,   Ca+2?, 1,   Ca+2↓, 3,   Ca+2↑, 36,   Ca+2↝, 2,   i-Ca+2↑, 3,   CAFs/TAFs↓, 1,   cal2↑, 2,   CCAT1↓, 2,   CCN2/CTGF↓, 3,   CD11b↑, 1,   CD38↓, 1,   CD38↑, 1,   Cdc42↓, 1,   Cdc42↑, 1,   Chl↑, 1,   Cofilin↓, 2,   COL1A1↓, 1,   COL3A1↓, 1,   COL4A3↓, 1,   E-cadherin↓, 10,   E-cadherin↑, 62,   E-cadherin↝, 1,   EMT?, 1,   EMT↓, 117,   EMT↑, 2,   EpCAM↓, 2,   F-actin↓, 3,   FAK↓, 13,   FAK↑, 2,   p‑FAK↓, 5,   Fibronectin↓, 5,   Furin↓, 1,   GLI2↓, 4,   GLI3↑, 1,   IQGAP3↓, 1,   ITGA5↓, 1,   ITGB1↓, 3,   ITGB4↓, 1,   ITGB6↓, 1,   KRAS↓, 1,   LAMs↓, 2,   LEF1↓, 1,   LIMK2↓, 1,   MALAT1↓, 2,   MET↓, 2,   MET↑, 1,   MMP-10↓, 2,   MMP1↓, 4,   MMP13↓, 4,   MMP14↓, 1,   MMP16↓, 2,   MMP17↓, 1,   MMP2↓, 102,   proMMP2↓, 1,   MMP3↓, 8,   MMP7↓, 7,   MMP9↓, 139,   MMP9↑, 2,   MMPs↓, 31,   MMPs↝, 1,   MTA1↓, 1,   MUC1↓, 1,   MUC4↓, 1,   N-cadherin↓, 42,   N-cadherin↑, 1,   N-cadherin↝, 1,   NCAM↓, 1,   NEDD9↓, 1,   p44↓, 1,   p44↑, 1,   p‑p44↓, 1,   PAK1↓, 3,   pax↓, 2,   PCBP1↓, 1,   PDGF↓, 6,   Rac1↓, 2,   RHBDD1↓, 1,   Rho↓, 5,   ROCK1↓, 3,   Sharpin↓, 1,   Slug↓, 16,   Smad1↓, 1,   Smad1↑, 1,   Smad1↝, 1,   SMAD2↓, 2,   p‑SMAD2↓, 5,   SMAD3↓, 5,   SMAD3↑, 1,   p‑SMAD3↓, 3,   SMAD4↓, 1,   p‑SMAD4↓, 1,   Snail?, 1,   Snail↓, 32,   Snail↑, 1,   SPARC↑, 2,   STAC2↓, 1,   talin?, 1,   talin↓, 1,   TET1↓, 1,   TET1↑, 3,   TGF-β↓, 21,   TGF-β↑, 2,   TGF-β↝, 1,   TGF-β1↓, 3,   THBS1↓, 1,   TIMP1↓, 2,   TIMP1↑, 14,   TIMP2↓, 1,   TIMP2↑, 11,   TIMP3↑, 1,   TRIB3↑, 1,   TSC1↑, 2,   TumCA↓, 6,   TumCA↑, 1,   TumCI↓, 258,   TumCI↑, 4,   TumCMig?, 1,   TumCMig↓, 293,   TumCMig↑, 6,   TumMeta↓, 139,   TumMeta↑, 9,   TumPF↓, 1,   Twist↓, 16,   Twist↑, 1,   TXNIP↑, 3,   uPA↓, 16,   uPAR↓, 3,   UroPA↓, 1,   Vim?, 1,   Vim↓, 52,   Vim↑, 2,   vinculin↓, 1,   Zeb1↓, 7,   ZEB2↓, 2,   ZEB2↑, 1,   α-SMA↓, 4,   α-SMA↑, 1,   α-tubulin↓, 2,   β-catenin/ZEB1↓, 77,   β-catenin/ZEB1↑, 2,   p‑β-catenin/ZEB1↑, 1,   cl‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 162,   angioG↑, 5,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 4,   EGR1↓, 1,   EGR1↑, 1,   EGR4↓, 1,   Endoglin↑, 2,   eNOS↓, 3,   HIF-1↓, 6,   Hif1a↓, 84,   Hif1a↑, 2,   Hif1a↝, 1,   Hypoxia↓, 2,   LOX1↓, 1,   NO↓, 7,   NO↑, 5,   PGI2↓, 1,   TYMP/ECGF1↓, 1,   VCAM-1↓, 4,   VEGF↓, 120,   VEGF↑, 1,   VEGF↝, 1,   VEGFR1↓, 5,   VEGFR2/KDR/Flk1↓, 15,   p‑VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

ABCG1↓, 1,   AQPs↓, 2,   BBB↑, 6,   BBB∅, 1,   CellMemb↑, 3,   CLDN1↓, 1,   CLDN1↑, 1,   CLDN2↓, 2,   EPR↑, 9,   GLUT1↓, 25,   GLUT1↑, 2,   GLUT1∅, 1,   GLUT2↓, 3,   GLUT3↓, 2,   GLUT3↑, 1,   GLUT3∅, 1,   GLUT4↓, 1,   IBI↑, 1,   KCNH2/hERG↓, 1,   MMP↓, 173,   MMP↑, 4,   MMP↝, 2,   MMP∅, 1,   MPT↓, 1,   MPT↑, 4,   NHE1↓, 1,   OATPs↓, 1,   OCLN↑, 1,   SLC12A5↓, 1,   SVCT-2↓, 1,   TJ↑, 1,   TRPM7↓, 1,   TRPM7↑, 1,   TRPV1↑, 3,   TRPV1↝, 1,   VGCC↑, 2,   VGSC↑, 1,   ZO-1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ANXA1↓, 1,   B2M↓, 1,   CB2 / CNR2↓, 1,   CB2 / CNR2↑, 3,   CD155↓, 2,   CD4+↓, 1,   CD4+↑, 5,   CD44↓, 19,   CD44↝, 1,   CD47↓, 1,   CD8+↑, 11,   cDC2↓, 1,   p‑cDC2↓, 1,   COX1↓, 3,   COX1↑, 1,   COX2/PTGS2↓, 85,   COX2/PTGS2↑, 2,   COX2/PTGS2↝, 1,   CXCL12↓, 2,   CXCL16↓, 1,   CXCL6/GCP-2↓, 1,   CXCL9↓, 1,   CXCR2↓, 2,   CXCR4↓, 14,   DCells↑, 1,   DR4↑, 11,   DR4∅, 1,   Eos↑, 1,   FOXP3↓, 1,   FOXP3↑, 1,   Gal-3↓, 3,   Gal1↑, 1,   HMGB1↓, 5,   HMGB1↑, 1,   ICAM-1↓, 9,   IFN-γ↓, 3,   IFN-γ↑, 3,   Igs↑, 2,   IL1↓, 3,   IL1↑, 2,   IL10↓, 2,   IL10↑, 2,   IL12↑, 3,   IL17↓, 1,   IL18↓, 2,   IL1α↓, 1,   IL1β↓, 22,   IL1β↑, 2,   IL2↓, 1,   IL2↑, 2,   IL4↓, 2,   IL4↑, 2,   IL5↓, 1,   IL6↓, 49,   IL6↑, 2,   IL8↓, 12,   IL8↑, 1,   Imm↑, 25,   Imm↝, 2,   Inflam↓, 65,   IRAK1↓, 1,   IRAK4↓, 1,   LIF↑, 1,   LRIG1↑, 1,   LTA/TNF-β↓, 1,   LTA/TNF-β↑, 1,   pol-M1↑, 2,   M2 MC↓, 4,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 4,   MCT1↓, 2,   MIP2↓, 1,   mPGES-1↓, 1,   MyD88↑, 1,   Neut↑, 1,   NF-kB?, 1,   NF-kB↓, 204,   NF-kB↑, 7,   NF-kB↝, 2,   p‑NF-kB↓, 3,   p‑NF-kB↑, 2,   NFKBIZ/IκBζ↓, 1,   NK cell↑, 7,   NLRP3↓, 6,   NLRP3↑, 3,   NOD1↓, 1,   p50↓, 1,   p65↓, 9,   p65↑, 1,   p‑p65↓, 1,   ac‑p65↓, 1,   ac‑p65↑, 1,   PD-1↓, 3,   PD-L1↓, 10,   PD-L1↑, 3,   PGE2↓, 13,   PSA↓, 17,   SOCS-3↑, 1,   T-Cell↑, 4,   TCF↓, 5,   Th1 response↑, 2,   TIGIT↓, 1,   TLR1↑, 1,   TLR2↑, 1,   TLR4↓, 6,   TLR4↑, 2,   TNF-α↓, 42,   TNF-α↑, 8,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 3,   TRADD↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   pH↓, 2,   pH↑, 1,   e-pH↑, 2,   i-pH↓, 1,   TAMS↓, 2,   TAMS↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   CAXII/CA12↑, 1,   ChE↓, 1,   PTN↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

6IL↑, 2,   ADRB2↓, 1,   AhR↓, 1,   AhR↑, 2,   AR↓, 24,   AR-V7?, 1,   COMT↓, 1,   CYP19?, 1,   CYP19↓, 2,   DHT↓, 1,   ER-α36↓, 3,   ER-α36↝, 1,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   FGF21↓, 1,   NR1H4↑, 1,   NR3C2/MR↑, 2,   PPARα↓, 1,   PPARα↝, 1,   PPARγ↓, 3,   PPARγ↑, 9,   PRL↓, 1,   RANKL↓, 2,   SRC3↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   AKR1B10↓, 1,   BioAv↓, 49,   BioAv↑, 50,   BioAv↝, 16,   BioEnh?, 1,   BioEnh↑, 1,   chemoR↓, 2,   ChemoSen?, 1,   ChemoSen↓, 4,   ChemoSen↑, 235,   ChemoSen⇅, 1,   ChemoSen↝, 1,   ChemoSen∅, 1,   CompStab↓, 2,   CompStab↑, 4,   CYP1A1↓, 3,   CYP1A1↑, 4,   CYP1A2↓, 1,   CYP1A2↑, 1,   CYP1B1↓, 2,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 2,   DDS↑, 4,   Dose?, 11,   Dose↓, 3,   Dose↑, 7,   Dose⇅, 3,   Dose↝, 108,   Dose∅, 9,   DrugR↓, 2,   eff?, 1,   eff↓, 104,   eff↑, 145,   eff⇅, 3,   eff↝, 14,   eff∅, 4,   GSTA1↓, 1,   GSTA1↑, 1,   GSTP1/GSTπ↑, 1,   GSTZ1↓, 1,   Half-Life↓, 12,   Half-Life↑, 4,   Half-Life↝, 11,   Half-Life∅, 1,   MDR1↓, 11,   MRP↓, 1,   MRP1/ABCC1↓, 5,   MRP2↓, 1,   MRP5↓, 1,   P-gp/ABCB1↓, 20,   P-gp/ABCB1↑, 1,   P450↓, 3,   RadioS?, 1,   RadioS↑, 63,   RadioS↝, 1,   selectivity?, 1,   selectivity↑, 150,   selectivity↝, 1,   selectivity∅, 1,   Synergy↑, 98,   Synergy↝, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 2,   ALAT↓, 5,   ALAT↑, 1,   ALB↑, 1,   ALP↓, 3,   ALP↑, 1,   AR↓, 24,   AST↓, 4,   AST↑, 1,   B2M↓, 1,   BloodF↓, 1,   BMD↑, 2,   BRAF↓, 1,   BRCA1↓, 3,   BUN↓, 1,   CRP↓, 2,   E6↓, 2,   E7↓, 2,   EGFR↓, 42,   p‑EGFR↓, 4,   ERα/ESR1↓, 1,   EZH2↓, 3,   Ferritin↓, 1,   Ferritin↑, 1,   FOXM1↓, 5,   HER2/EBBR2↓, 13,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 13,   IL6↓, 49,   IL6↑, 2,   KRAS↓, 1,   LDH↓, 12,   LDH↑, 4,   LDH↝, 2,   e-LDH↑, 1,   Maspin↑, 1,   Myc↓, 5,   Myc↑, 1,   NOS2↓, 1,   PD-L1↓, 10,   PD-L1↑, 3,   Polyps↓, 2,   PSA↓, 17,   TP53↓, 1,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 9,   Tumccf↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↓, 3,   AntiCan↑, 87,   AntiCan∅, 1,   antiD↑, 1,   antiNeop↑, 6,   AntiTum↓, 2,   AntiTum↑, 37,   cachexia↓, 3,   cardioP↑, 6,   CardioT↓, 1,   CardioT↑, 1,   chemoP?, 1,   chemoP↑, 48,   chemoPv↑, 32,   ChemoSideEff↓, 5,   ChemoSideEff∅, 1,   fatigue↓, 1,   FTO↓, 1,   FTO↑, 2,   hepatoP↓, 1,   hepatoP↑, 9,   kidSt↓, 1,   neuroP↓, 1,   neuroP↑, 11,   NP/CIPN↓, 3,   OS↑, 30,   OS∅, 1,   Pain↓, 3,   PFS↑, 1,   PFS∅, 1,   Pin1↓, 2,   QoL↑, 11,   QoL∅, 1,   radioP↑, 15,   Remission↑, 2,   RenoP↑, 8,   Risk↓, 39,   Risk↑, 1,   Strength↑, 1,   TGFβR1↓, 1,   toxicity?, 1,   toxicity↓, 42,   toxicity↑, 6,   toxicity⇅, 1,   toxicity↝, 14,   toxicity∅, 3,   TumNum?, 1,   TumNum↓, 2,   TumVol?, 1,   TumVol↓, 58,   TumVol↑, 1,   TumVol∅, 1,   TumW↓, 30,   TumW∅, 1,   Weight↑, 1,   Weight∅, 4,   Wound Healing↓, 2,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiP↑, 2,   Bacteria↓, 2,   GutMicro↑, 11,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Api↑, 1,   Ingr?, 4,   Ingr↑, 1,   Ingr↝, 18,  
Total Targets: 1504

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 8,   antiOx↑, 101,   mt-antiOx↑, 1,   ARE↑, 2,   Catalase↑, 33,   Fenton↓, 1,   GPx↑, 26,   GPx1↑, 1,   GPx4↑, 1,   GSH↓, 2,   GSH↑, 31,   GSR↑, 7,   GSTs↑, 8,   H2O2↓, 3,   HDL↓, 1,   HDL↑, 4,   HO-1?, 1,   HO-1↓, 2,   HO-1↑, 21,   hyperG↓, 1,   hyperG↝, 1,   Keap1↓, 4,   Keap1↝, 1,   lipid-P↓, 26,   MDA↓, 20,   MDA↑, 1,   MPO↓, 4,   NADH↓, 1,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 4,   NRF2↓, 2,   NRF2↑, 40,   RNS↓, 5,   ROS?, 3,   ROS↓, 83,   ROS↑, 7,   ROS⇅, 1,   ROS∅, 1,   mt-ROS?, 1,   selenoP↑, 1,   SOD↑, 36,   SOD1↑, 6,   SOD2↑, 3,   TAC↑, 4,   TBARS↓, 2,   VitC↑, 2,   VitE↓, 1,   VitE↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 3,   IronCh↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   DRP1/DNM1L↓, 1,   HSP60/HSPD1↓, 1,   Insulin↓, 1,   Insulin↑, 2,   MFN2↑, 1,   mitResp↑, 2,   mtDam↓, 1,   OCR↑, 1,   PGC-1α↝, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   ACSL4↓, 1,   ALAT↓, 9,   AMPK↑, 6,   ATP↓, 1,   ATP↑, 6,   CRM↑, 1,   ECAR↓, 1,   ECAR∅, 1,   glucose↓, 6,   glucose↑, 1,   glucose↝, 1,   GlucoseCon↑, 4,   glyC↓, 1,   Glycolysis↓, 1,   Glycolysis↑, 1,   GSK‐3β↓, 1,   GSK‐3β↑, 2,   HK2↑, 1,   HMG-CoA↓, 1,   LDHA↑, 1,   LDL↓, 7,   lipidLev↓, 2,   NADPH↓, 1,   SIRT1↑, 3,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   AIF↑, 1,   Apoptosis↓, 5,   ASC↓, 1,   BAX↓, 3,   BAX↑, 2,   Bcl-2↓, 2,   Bcl-2↑, 3,   Bcl-xL↑, 1,   Casp1↓, 1,   Casp12↓, 1,   Casp3↓, 8,   Casp3↑, 2,   cl‑Casp3↓, 1,   cl‑Casp8↓, 1,   cl‑Casp8↑, 1,   Casp9↓, 4,   Cyt‑c↓, 1,   Cyt‑c↑, 1,   Fas↓, 2,   FasL↓, 1,   Ferroptosis↓, 2,   GranB/GZMB↓, 1,   IAP1↓, 1,   iNOS↓, 11,   iNOS↑, 2,   necrosis↓, 1,   p38↓, 3,   p‑p38↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 6,   Akt↝, 1,   p‑Akt↑, 2,   ERK↓, 1,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IGF-1R↓, 1,   IKKα↓, 1,   IκB?, 1,   JAK↓, 1,   JAK2↑, 1,   JNK↓, 2,   JNK↑, 2,   p‑JNK↓, 4,   MAPK↓, 7,   MAPK↑, 1,   MAPK↝, 1,   mTOR↓, 3,   mTOR↑, 2,   PDGFR-BB↓, 1,   PI3K↓, 2,   PI3K↑, 5,   PKCδ↓, 1,   PKCδ↑, 1,   RIP1↓, 1,   STAT↓, 1,   STAT3↓, 2,   STAT3↑, 2,   STAT3↝, 1,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 4,   ATF2↑, 1,   ATF4↓, 1,   cMyc↓, 1,   FOXO3↑, 1,   HDAC↓, 1,   HOTAIR↑, 1,   other?, 1,   other↓, 4,   other↑, 3,   other↝, 8,   PhotoS↑, 1,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 1,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,   HSP27↓, 1,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↑, 2,   p62↑, 2,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 2,   P53↑, 1,   PARP↑, 1,   PARP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 1,   E2Fs↑, 1,   P21↑, 2,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   Diff↑, 1,   Diff↝, 1,   EP2↓, 1,   FGF↑, 1,   HH↓, 1,   neuroG↑, 2,   NOTCH↓, 1,   TumCP↓, 10,   TumCP↑, 1,   Wnt↓, 1,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 8,   AP-1↓, 2,   BACH1↓, 1,   Ca+2↓, 2,   Ca+2↑, 1,   Ca+2↝, 1,   Cartilage↑, 1,   EMT↑, 1,   FAK↑, 1,   LAMs↑, 1,   MMP13↓, 1,   MMP2↓, 1,   MMP2↑, 1,   MMP9↓, 2,   Smad1↑, 1,   TGF-β↓, 2,   TGF-β↑, 3,   TumCI↓, 2,   TumCMig↓, 2,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 3,   angioG↑, 1,   E-sel↓, 1,   Hif1a↓, 1,   NO↓, 11,   VCAM-1↓, 4,   VEGF↓, 3,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↓, 1,   BBB↑, 6,   BBB↝, 1,   GastroP↑, 3,   GLUT1↓, 1,   GLUT2↑, 1,   GLUT4↑, 2,   H+/K+-ATPase↓, 1,   IBI↑, 3,   MMP↓, 3,   MMP↑, 4,   MMP∅, 1,   SVCT-2↑, 1,   TRPV1↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   COX1↓, 4,   COX2/PTGS2↓, 23,   COX2/PTGS2↑, 1,   FOXP3↑, 1,   HMGB1↓, 1,   ICAM-1↓, 4,   IFN-γ↓, 6,   IFN-γ↑, 1,   IL1↓, 2,   IL10↓, 2,   IL10↑, 3,   IL12↓, 2,   IL17↓, 1,   IL18↓, 1,   IL1β↓, 22,   IL2↓, 1,   IL23↓, 1,   IL4↓, 2,   IL4↑, 1,   IL6?, 1,   IL6↓, 22,   IL6↑, 1,   IL8↓, 4,   Imm↑, 11,   Imm⇅, 1,   Imm↝, 1,   Inflam?, 1,   Inflam↓, 106,   Inflam↑, 1,   IRF3↓, 2,   LPS↓, 1,   M2 MC↑, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 2,   MCP1/CCL2↑, 1,   MyD88↓, 2,   NF-kB?, 1,   NF-kB↓, 28,   NF-kB↑, 2,   NK cell↑, 1,   NLRP3↓, 6,   NLRP3↑, 2,   p65↓, 1,   PGE2↓, 6,   RAGE↓, 1,   SOCS-3↓, 1,   TLR2↓, 2,   TLR4↓, 6,   TLR4↑, 1,   TLR4∅, 1,   TNF-α?, 1,   TNF-α↓, 29,   TNF-α↑, 1,   Treg lymp↝, 1,   TRIF↓, 1,   β-HEX↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 2,   Ach↑, 1,   AChE↓, 12,   AChE↑, 1,   BChE↓, 3,   BDNF↑, 7,   proBDNF↑, 1,   ChAT↑, 1,   GABA↑, 2,   MAOA↓, 1,   MAOB↓, 1,   NGF↑, 4,   TPH1↓, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 3,   APP↓, 1,   Aβ↓, 10,   BACE/β-secretase↓, 3,   tau↓, 1,   p‑tau↓, 3,   XO↓, 1,   XO↝, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE2↓, 1,   AHR↓, 1,   Estro↓, 1,   PPARγ↑, 1,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 37,   BioAv↑, 49,   BioAv↝, 21,   BioEnh↑, 2,   CompStab↝, 1,   CYP1A1↑, 1,   CYP1A2↑, 1,   Dose↓, 1,   Dose↑, 2,   Dose↝, 15,   eff↓, 1,   eff↑, 9,   eff↝, 2,   GSTA1↑, 2,   Half-Life↓, 2,   Half-Life↑, 1,   Half-Life↝, 9,   Half-Life∅, 1,   P-gp/ABCB1↓, 1,   P450↓, 1,   P450↑, 1,   selectivity↑, 1,   Synergy↑, 4,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 9,   ALP↓, 2,   AST↓, 10,   BG↓, 1,   BloodF↑, 1,   BMD↑, 3,   BP↓, 7,   creat↓, 2,   CRP↓, 3,   HOMA↓, 1,   hs-CRP↓, 1,   IL6?, 1,   IL6↓, 22,   IL6↑, 1,   IRes↝, 1,   LDH↓, 4,   NOS2↓, 2,   RAGE↓, 1,   SpO2↑, 1,   TC↓, 2,   TG/TAG↓, 2,   Urea↓, 1,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 7,   antiAll↑, 13,   AntiArt↑, 6,   AntiCan↓, 2,   AntiCan↑, 21,   antiCG↑, 2,   antiD↑, 1,   AntiDiabetic↓, 3,   AntiDiabetic↑, 22,   antiPs↑, 2,   AntiTum↑, 9,   ANXi↓, 1,   Bone Healing↑, 1,   cardioP?, 1,   cardioP↑, 34,   CardioT↓, 1,   chemoP↑, 8,   chemoPv↑, 5,   cognitive↓, 1,   cognitive↑, 16,   diuretic↑, 2,   hepatoP↓, 2,   hepatoP↑, 37,   Learn↑, 1,   memory↑, 14,   Mood↑, 1,   motorD↓, 1,   neuroP?, 1,   neuroP↓, 1,   neuroP↑, 59,   Obesity↓, 15,   OS↑, 1,   Pain↓, 1,   QoL↓, 1,   radioP↑, 3,   RenoP↓, 1,   RenoP↑, 14,   Risk↓, 2,   Sleep↑, 2,   Stress↓, 2,   Stroke↓, 11,   toxicity↓, 48,   toxicity↑, 3,   toxicity↝, 9,   toxicity∅, 12,   Weight↑, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 11,   AntiFungal↑, 4,   AntiP↓, 1,   AntiP↑, 3,   AntiViral↑, 13,   Bacteria↓, 21,   GutMicro↑, 16,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Api↑, 1,   CA↑, 1,   Catechins↑, 1,   FA↑, 1,   Fibre↑, 1,   GA↑, 1,   Ingr↑, 2,   Ingr↝, 7,   LT↑, 1,   Myr↑, 1,   Phen↑, 1,   Poly↑, 1,   QC↑, 2,  
Total Targets: 448

Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
44 Curcumin
25 Quercetin
24 Luteolin
24 Thymoquinone
23 Magnetic Fields
23 Shikonin
19 EGCG (Epigallocatechin Gallate)
19 Sulforaphane (mainly Broccoli)
18 Berberine
18 Resveratrol
18 Matrine
17 Phenethyl isothiocyanate
17 Kaempferol
17 Licochalcone A
16 Silver-NanoParticles
16 Radiotherapy/Radiation
16 Baicalein
14 Cisplatin
14 Apigenin (mainly Parsley)
14 Melatonin
14 Capsaicin
14 phytic acid, Inositol hexakisphosphate
13 Propolis -bee glue
13 Formononetin
13 Honokiol
13 Magnolol
12 Artemisinin
12 Fisetin
12 Garcinol
12 Lycopene
11 Ashwagandha(Withaferin A)
11 Astaxanthin
11 Boron
11 Metformin
11 Crocetin
11 Emodin
11 Isorhamnetin
11 Juglone
11 Nimbolide
10 Chrysin
10 itraconazole
10 Selenite (Sodium)
10 Silymarin (Milk Thistle) silibinin
10 Urolithin
9 Berbamine
9 Flaxseed/Linseed
9 Gallic acid
9 Hyperoside
9 Ivermectin
8 Citric Acid
8 5-fluorouracil
8 chitosan
8 Beta-Caryophyllene
8 chaetocin
8 Dandelion Root
8 HydroxyTyrosol
8 Isobavachalcone
8 Isoliquiritigenin
8 Licorice
7 Astragalus
7 Benzyl isothiocyanate
7 Anethole/trans-Anethole
7 Paclitaxel/Taxol
7 Bufalin/Huachansu
7 Centella asiatica / Gotu kola → asiaticoside
7 Eugenol
7 Evodiamine
7 Ferulic acid
7 Gambogic Acid
7 Ginkgetin
7 isoorientin
7 Linalool
7 mebendazole
7 Mangiferin
7 Piperlongumine
6 Boswellia (frankincense)
6 Chemotherapy
6 Carnosic acid
6 Rosmarinic acid
6 Celastrol
6 Carvone
6 Cucurbitacin
6 Diclofenac
6 Diindolylmethane
6 Ellagic acid
6 isoquercitrin
6 Lemongrass Extract/Citral
6 Morin
6 Mushroom Lion’s Mane, Hericium erinaceus
6 Phenylbutyrate
6 salinomycin
6 Zyflamend
5 Allyl isothiocyanate
5 DTS(dibenzyl trisulphide) from Anamu
5 Gemcitabine (Gemzar)
5 Betulinic acid
5 Carvacrol
5 Cinnamon
5 Copper and Cu NanoParticles
5 Deguelin
5 Indole-3-carbinol
5 D-limonene
5 Fucoidan
5 Galloflavin
5 Geraniol
5 Hydrogen Gas
5 Helleborus niger extracts – Christmas Rose
5 low dose naltrexone
5 Magnetic Field Rotating
5 Patchouli Oil (Pogostemon cablin)
5 Vitamin K2
4 Allicin (mainly Garlic)
4 Atorvastatin
4 brusatol
4 Celecoxib
4 Chlorogenic acid
4 Chlorophyllin
4 Photodynamic Therapy
4 Date Fruit Extract
4 Disulfiram
4 Genistein (soy isoflavone)
4 Fenbendazole
4 Ginger/6-Shogaol/Gingerol
4 iodine
4 Inositol
4 Lutein
4 Marjoram (Origanum majorana)
4 Phycocyanin
4 Piperine
4 Ursolic acid
3 1,8-Cineole
3 Alpha-Lipoic-Acid
3 Andrographis
3 Isovitexin
3 Aspirin
3 immunotherapy
3 Docetaxel
3 α-Bisabolol / Chamomile oil
3 Butyrate
3 Caffeic acid
3 Thymol-Thymus vulgaris
3 Chocolate
3 Cichoric acid / Chicoric acid
3 Cyclopamine
3 Cynaropicrin
3 Dichloroacetate
3 diet Methionine-Restricted Diet
3 Ginkgo biloba-EGb 761
3 Ginkgo biloba
3 Ginkgolide B
3 Vitamin C (Ascorbic Acid)
3 Lactoferrin/Talactoferrin
3 Methylene blue
3 Moringa oleifera
3 Mushroom Chaga, Inonotus obliquus
3 Oleuropein
3 Propyl gallate
3 Plumbagin
3 Pterostilbene
3 Selenium
3 Sesamin
3 Terpinen-4-ol / Tea Tree Oil
3 Aflavin-3,3′-digallate
3 VitK3,menadione
3 Walnut
3 Zerumbone
2 Sorafenib (brand name Nexavar)
2 3-bromopyruvate
2 Auranofin
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Ascorbyl Palmitate
2 Arctigenin
2 Baicalin
2 Biochanin A
2 Isothiocyanates
2 Brucea javanica
2 Bacopa monnieri
2 Beetroot
2 Caffeic Acid Phenethyl Ester (CAPE)
2 Hydroxycinnamic-acid
2 Coenzyme Q10
2 Carica papaya leaf extract
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Dichloroacetophenone(2,2-)
2 diet FMD Fasting Mimicking Diet
2 diet Short Term Fasting
2 Echinacea
2 Eurycomanone
2 Flaxseed Oil
2 Arsenic trioxide
2 Ginkgolic acids
2 γ-linolenic acid (Borage Oil)
2 Graviola
2 Grapeseed extract
2 hydrogen sulfide
2 doxorubicin
2 Laetrile B17 Amygdalin
2 lambertianic acid
2 Lapachol
2 SDG/lignans
2 Mung Bean Sprouts
2 Modified Citrus Pectin
2 Lemon Balm/Melissa officinalis
2 Methylsulfonylmethane
2 Mistletoe/Viscum album Extracts
2 Naringin
2 Niclosamide (Niclocide)
2 Psoralidin
2 EMF
2 Rutin
2 α-Santalol/Sandalwood oil
2 Sulfasalazine
2 Salvia miltiorrhiza
2 Vitamin D3
1 2-DeoxyGlucose
1 Açaí, Euterpe oleracea
1 Glucose
1 SonoDynamic Therapy UltraSound
1 Zinc
1 Ajoene (compound of Garlic)
1 alpha Linolenic acid
1 Fennel Oil/Foeniculum vulgare
1 Aloe anthraquinones
1 beta-glucans
1 almonertinib
1 bempedoic acid
1 Bevacizumab (brand Avastin)
1 temozolomide
1 Bromelain
1 borneol
1 Bortezomib
1 Bruteridin(bergamot juice)
1 Black turtle bean
1 Bullatacin
1 hydroxychloroquine
1 Cat’s Claw
1 Cynanbungeigenin C (CBC) and D (CBD)
1 Cannabidiol
1 Camu camu
1 Camptothecin
1 irinotecan
1 Cranberry
1 CUSP9
1 Dasatinib/Phyrago
1 Dihydrocaffeic Acid
1 Electrical Pulses
1 Exercise
1 Vitamin E
1 ferumoxytol
1 Trastuzumab
1 tamoxifen
1 Vitamin A, Retinoic Acid
1 Shilajit/Fulvic Acid
1 Ginseng
1 Germacranolide sesquiterpene lactone
1 Siegesbeckia glabrescens
1 HydroxyCitric Acid
1 epipolythiodioxopiperazine / epipolythiopiperazine-2,5-dione
1 Hibiscus sabdariffa
1 Hops (Humulus lupulus)
1 Hyperthermia
1 Inoscavin A
1 Recombinant Methioninase
1 L-Theanine
1 Lactobacillus
1 MCT, metronomic chemo
1 Methyl Jasmonate
1 methylseleninic acid
1 Caffeine
1 Magnesium
1 Methylglyoxal
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 magnetic nanoparticles
1 Mucuna pruriens/Velvet Bean
1 Mushroom Maitake
1 nicotinamide adenine dinucleotide
1 Bicarbonate(Sodium)
1 Oroxylin-A
1 Oleocanthal
1 Proanthocyanidins
1 sericin
1 Purple Corn / Purple Maize
1 xanthohumol
1 Pomi-T
1 Propranolol
1 Gold NanoParticles
1 Rauwolfia serpentina/Indian Snakeroot
1 buckwheat sprouts
1 Oxaliplatin
1 Selenium NanoParticles
1 Lignans
1 diet Plant based
1 Spirulina(Arthrospira/Limnospira)
1 Spermidine
1 tetrathiomolybdate
1 Tumor Treating Fields
1 Turmerones
1 Usnic acid
1 Vitexin
1 Wogonin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:327  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page